Hydrokortison Orion

Hydrocortisone, the active ingredient in Hydrokortison Orion, is a corticosteroid (glucocorticoid) presented as an oral formulation for systemic use. It replaces deficient cortisol in patients with adrenal insufficiency and related disorders, helping to restore normal metabolic and stress‑response functions, and provides anti‑inflammatory and immunosuppressive activity when required.

GNH USA supplies Hydrokortison Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to EU quality standards and provides reliable logistics for global distribution efficiently.

Hydrocortisone is used to replace cortisol in disorders of adrenal hormone production. - Adrenal insufficiency (Addison's disease): restores deficient cortisol levels to maintain metabolic stability. - Congenital adrenal hyperplasia: provides glucocorticoid replacement to suppress excess androgen production. - Secondary adrenal insufficiency: compensates for reduced ACTH‑stimulated cortisol output after pituitary or hypothalamic dysfunction. - Corticosteroid replacement therapy: supplies physiologic glucocorticoid doses for patients requiring long‑term hormone support.

Hydrocortisone may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Mild gastrointestinal upset: nausea, abdominal discomfort or dyspepsia. - Transient increase in blood glucose: mild hyperglycemia, especially in diabetic patients. - Fluid retention: mild edema or weight gain. - Mood changes: irritability or insomnia.

Serious or Rare Side Effects: - Severe infection risk: immunosuppression may predispose to opportunistic infections. - Adrenal crisis on abrupt discontinuation: sudden loss of cortisol leading to hypotension and shock. - Allergic reactions: rash, urticaria, or anaphylaxis.

Before prescribing hydrocortisone, clinicians should consider several precautionary measures to ensure safe use. - Assess adrenal function: confirm diagnosis of cortisol deficiency before initiating therapy. - Monitor blood glucose: patients with diabetes may require dose adjustments. - Screen for infections: evaluate for latent tuberculosis or active infections prior to treatment. - Taper gradually: avoid abrupt cessation to prevent adrenal insufficiency. - Use with caution in pregnancy: weigh potential benefits against unknown fetal risks. - Store at ambient temperature: keep below 25°C in the original container, protect from moisture.

Hydrocortisone can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Potent CYP3A4 inducers (e.g., rifampicin, phenytoin): may markedly reduce hydrocortisone plasma levels. - Long‑acting glucocorticoids (e.g., dexamethasone): concurrent use can cause excessive glucocorticoid effects.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): hydrocortisone may enhance anticoagulant effect, requiring INR monitoring. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase risk of gastrointestinal ulceration. - Vaccines (live attenuated): immunosuppression may diminish vaccine efficacy.